Screening assays

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C12Q 1/02 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2092000

2092000 9205286 PCTABS00011 A method for the identification of compounds as inhibitors of oncoprotein action is described. A compound is identified as an inhibitor of oncoprotein action based on its ability to modulate the transcription of a reporter gene. Transcription of the reporter gene is dependent upon the binding of a fusion oncoprotein to a specific DNA binding element positioned upstream of the reporter gene promoter. The fusion oncoprotein contains a transcriptional regulatory domain from an oncoprotein and a DNA binding domain from a different protein.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Screening assays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assays will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1747140

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.